Concepts (259)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spasms, Infantile | 28 | 2015 | 166 | 2.480 |
Why?
|
| Electroencephalography | 45 | 2015 | 863 | 1.510 |
Why?
|
| Seizures | 17 | 2013 | 890 | 1.240 |
Why?
|
| Psychophysiologic Disorders | 3 | 2013 | 25 | 1.080 |
Why?
|
| Epilepsy | 10 | 2012 | 876 | 0.490 |
Why?
|
| Neocortex | 4 | 2015 | 75 | 0.450 |
Why?
|
| Brain Diseases | 2 | 2008 | 299 | 0.400 |
Why?
|
| Psychotherapy, Brief | 1 | 2013 | 53 | 0.390 |
Why?
|
| Consciousness | 2 | 2012 | 56 | 0.390 |
Why?
|
| Sensation Disorders | 1 | 2012 | 25 | 0.360 |
Why?
|
| Adrenocorticotropic Hormone | 11 | 2010 | 61 | 0.330 |
Why?
|
| Hippocampus | 7 | 2009 | 806 | 0.320 |
Why?
|
| Brain | 9 | 2008 | 3175 | 0.320 |
Why?
|
| Tetrodotoxin | 4 | 2012 | 48 | 0.320 |
Why?
|
| Patient Education as Topic | 1 | 2013 | 464 | 0.320 |
Why?
|
| Sodium Channel Blockers | 1 | 2007 | 24 | 0.260 |
Why?
|
| Infant, Newborn | 17 | 2013 | 8635 | 0.250 |
Why?
|
| Infant | 31 | 2015 | 13352 | 0.250 |
Why?
|
| Video Recording | 5 | 2012 | 193 | 0.240 |
Why?
|
| Epilepsies, Partial | 7 | 2006 | 85 | 0.240 |
Why?
|
| Disease Models, Animal | 8 | 2015 | 4697 | 0.230 |
Why?
|
| Signal Processing, Computer-Assisted | 5 | 2009 | 119 | 0.220 |
Why?
|
| Videotape Recording | 3 | 2007 | 54 | 0.180 |
Why?
|
| Monitoring, Physiologic | 6 | 2007 | 376 | 0.170 |
Why?
|
| Movement | 4 | 2006 | 147 | 0.170 |
Why?
|
| Animals, Newborn | 7 | 2012 | 1021 | 0.170 |
Why?
|
| Rats | 12 | 2015 | 3370 | 0.160 |
Why?
|
| Models, Biological | 1 | 2005 | 1371 | 0.150 |
Why?
|
| Humans | 54 | 2015 | 131163 | 0.150 |
Why?
|
| Anticonvulsants | 5 | 2015 | 363 | 0.140 |
Why?
|
| Shal Potassium Channels | 2 | 2009 | 48 | 0.140 |
Why?
|
| Neuronal Plasticity | 1 | 2000 | 283 | 0.130 |
Why?
|
| Prednisone | 5 | 1991 | 235 | 0.130 |
Why?
|
| Vigabatrin | 2 | 2015 | 19 | 0.130 |
Why?
|
| Age Factors | 6 | 2012 | 2825 | 0.120 |
Why?
|
| Status Epilepticus | 3 | 2009 | 159 | 0.120 |
Why?
|
| Spasm | 3 | 2012 | 46 | 0.120 |
Why?
|
| Tetanus Toxin | 5 | 2001 | 21 | 0.120 |
Why?
|
| Rats, Wistar | 7 | 2007 | 299 | 0.110 |
Why?
|
| Prospective Studies | 7 | 2012 | 6459 | 0.110 |
Why?
|
| Diagnosis, Computer-Assisted | 5 | 2006 | 88 | 0.100 |
Why?
|
| Coma | 2 | 1984 | 56 | 0.100 |
Why?
|
| Pyramidal Cells | 3 | 2009 | 151 | 0.090 |
Why?
|
| Male | 17 | 2015 | 64957 | 0.090 |
Why?
|
| Animals | 15 | 2015 | 33912 | 0.090 |
Why?
|
| Genetics, Behavioral | 1 | 2011 | 8 | 0.080 |
Why?
|
| Hyperventilation | 1 | 2011 | 12 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 423 | 0.080 |
Why?
|
| Synaptic Transmission | 3 | 2008 | 299 | 0.080 |
Why?
|
| Psychological Tests | 1 | 2011 | 86 | 0.080 |
Why?
|
| Behavior, Animal | 5 | 2007 | 480 | 0.080 |
Why?
|
| Photic Stimulation | 1 | 2011 | 227 | 0.080 |
Why?
|
| Age of Onset | 3 | 2008 | 592 | 0.080 |
Why?
|
| Methysergide | 1 | 1989 | 1 | 0.080 |
Why?
|
| Methyltyrosines | 1 | 1989 | 3 | 0.080 |
Why?
|
| Child, Preschool | 14 | 2008 | 15110 | 0.080 |
Why?
|
| Middle Aged | 6 | 2013 | 28601 | 0.080 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 1989 | 46 | 0.080 |
Why?
|
| Epilepsy, Benign Neonatal | 2 | 2006 | 12 | 0.080 |
Why?
|
| Alpha Rhythm | 2 | 1995 | 9 | 0.070 |
Why?
|
| Convulsants | 1 | 2009 | 15 | 0.070 |
Why?
|
| Meningitis | 2 | 2008 | 96 | 0.070 |
Why?
|
| Trinucleotide Repeats | 1 | 2009 | 83 | 0.070 |
Why?
|
| Diagnosis, Differential | 2 | 2006 | 1882 | 0.070 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2012 | 830 | 0.070 |
Why?
|
| Electrodes, Implanted | 2 | 2007 | 180 | 0.070 |
Why?
|
| Tetrabenazine | 1 | 1988 | 38 | 0.070 |
Why?
|
| Brain Injury, Chronic | 1 | 2008 | 17 | 0.070 |
Why?
|
| Consensus | 1 | 2010 | 512 | 0.070 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2010 | 361 | 0.070 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2007 | 33 | 0.070 |
Why?
|
| Remission, Spontaneous | 2 | 2002 | 62 | 0.070 |
Why?
|
| Female | 11 | 2013 | 70963 | 0.060 |
Why?
|
| HLA Antigens | 1 | 1988 | 221 | 0.060 |
Why?
|
| Joints | 1 | 2007 | 25 | 0.060 |
Why?
|
| Immersion | 1 | 1987 | 6 | 0.060 |
Why?
|
| Cerebrovascular Disorders | 1 | 2008 | 111 | 0.060 |
Why?
|
| Contracture | 1 | 2007 | 26 | 0.060 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2008 | 95 | 0.060 |
Why?
|
| Encephalitis | 1 | 2008 | 122 | 0.060 |
Why?
|
| Infant Behavior | 1 | 2006 | 15 | 0.060 |
Why?
|
| Motion | 1 | 2006 | 37 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2010 | 1490 | 0.060 |
Why?
|
| Automation | 1 | 2006 | 65 | 0.060 |
Why?
|
| Pattern Recognition, Automated | 1 | 2006 | 40 | 0.060 |
Why?
|
| Homeodomain Proteins | 1 | 2009 | 555 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2013 | 12936 | 0.060 |
Why?
|
| Drowning | 1 | 1987 | 48 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2012 | 5196 | 0.060 |
Why?
|
| Face | 1 | 2007 | 192 | 0.060 |
Why?
|
| Sensitivity and Specificity | 5 | 2009 | 2085 | 0.060 |
Why?
|
| Cognition Disorders | 1 | 2009 | 556 | 0.050 |
Why?
|
| Sleep | 3 | 1992 | 381 | 0.050 |
Why?
|
| Child Development | 4 | 1991 | 266 | 0.050 |
Why?
|
| Carbamazepine | 3 | 1999 | 40 | 0.050 |
Why?
|
| Neurotransmitter Agents | 1 | 2005 | 134 | 0.050 |
Why?
|
| Immune System Diseases | 1 | 2005 | 58 | 0.050 |
Why?
|
| Time Factors | 4 | 2008 | 6196 | 0.050 |
Why?
|
| Myelin Sheath | 1 | 2005 | 131 | 0.050 |
Why?
|
| Algorithms | 3 | 2009 | 1680 | 0.050 |
Why?
|
| Sudden Infant Death | 1 | 1984 | 36 | 0.050 |
Why?
|
| Adrenal Cortex Hormones | 3 | 2010 | 333 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 2 | 2010 | 1295 | 0.050 |
Why?
|
| Nervous System | 1 | 1984 | 114 | 0.050 |
Why?
|
| Aging | 3 | 2007 | 1242 | 0.050 |
Why?
|
| Adult | 3 | 2012 | 31282 | 0.040 |
Why?
|
| Mental Disorders | 1 | 2009 | 910 | 0.040 |
Why?
|
| Synapses | 1 | 2005 | 425 | 0.040 |
Why?
|
| Abnormalities, Multiple | 1 | 2007 | 963 | 0.040 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2010 | 1168 | 0.040 |
Why?
|
| Excitatory Amino Acids | 1 | 2000 | 9 | 0.040 |
Why?
|
| Space Perception | 1 | 2001 | 50 | 0.040 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1983 | 177 | 0.040 |
Why?
|
| Maze Learning | 1 | 2001 | 96 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2010 | 3763 | 0.040 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2006 | 789 | 0.040 |
Why?
|
| Nerve Degeneration | 1 | 2001 | 128 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2009 | 2406 | 0.040 |
Why?
|
| Mossy Fibers, Hippocampal | 1 | 1999 | 9 | 0.040 |
Why?
|
| Epilepsy, Temporal Lobe | 2 | 1992 | 92 | 0.030 |
Why?
|
| Sleep Wake Disorders | 1 | 1981 | 204 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2010 | 3147 | 0.030 |
Why?
|
| Clinical Trials as Topic | 4 | 1991 | 1129 | 0.030 |
Why?
|
| Recurrence | 4 | 1999 | 1489 | 0.030 |
Why?
|
| Health Occupations | 1 | 1977 | 32 | 0.030 |
Why?
|
| Attitude | 1 | 1977 | 111 | 0.030 |
Why?
|
| Risk Factors | 1 | 2011 | 11074 | 0.030 |
Why?
|
| Cerebral Cortex | 3 | 1994 | 445 | 0.030 |
Why?
|
| Veterans | 1 | 2007 | 1763 | 0.030 |
Why?
|
| Career Choice | 1 | 1977 | 166 | 0.030 |
Why?
|
| Child | 9 | 2002 | 26341 | 0.030 |
Why?
|
| Students | 1 | 1977 | 250 | 0.030 |
Why?
|
| Aged | 2 | 2011 | 21025 | 0.030 |
Why?
|
| Dominance, Cerebral | 1 | 1994 | 49 | 0.030 |
Why?
|
| Evoked Potentials | 1 | 1994 | 113 | 0.030 |
Why?
|
| Injections | 3 | 1999 | 109 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 1994 | 238 | 0.020 |
Why?
|
| Polysomnography | 1 | 1994 | 153 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2015 | 384 | 0.020 |
Why?
|
| Action Potentials | 2 | 2009 | 476 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 1994 | 732 | 0.020 |
Why?
|
| Aphasia, Wernicke | 1 | 1992 | 1 | 0.020 |
Why?
|
| Decision Making | 1 | 1977 | 726 | 0.020 |
Why?
|
| Hydrocortisone | 2 | 1983 | 215 | 0.020 |
Why?
|
| Tomography, Emission-Computed | 1 | 1991 | 35 | 0.020 |
Why?
|
| Prednisolone | 1 | 2010 | 74 | 0.020 |
Why?
|
| Diet, Ketogenic | 1 | 2010 | 26 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 2010 | 110 | 0.020 |
Why?
|
| alpha-Methyltyrosine | 1 | 1989 | 3 | 0.020 |
Why?
|
| Barbiturates | 1 | 1989 | 7 | 0.020 |
Why?
|
| Phenytoin | 1 | 1989 | 54 | 0.020 |
Why?
|
| Phenotype | 2 | 2009 | 4497 | 0.020 |
Why?
|
| Anesthetics | 1 | 2010 | 75 | 0.020 |
Why?
|
| Channelopathies | 1 | 2009 | 12 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2010 | 294 | 0.020 |
Why?
|
| Cognition | 1 | 1995 | 829 | 0.020 |
Why?
|
| Pyridoxine | 1 | 1989 | 15 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2009 | 118 | 0.020 |
Why?
|
| Perfusion | 1 | 2010 | 209 | 0.020 |
Why?
|
| Hypnotics and Sedatives | 1 | 2010 | 132 | 0.020 |
Why?
|
| Television | 2 | 1999 | 70 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2009 | 272 | 0.020 |
Why?
|
| Random Allocation | 1 | 1989 | 409 | 0.020 |
Why?
|
| Artifacts | 1 | 2009 | 100 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2009 | 234 | 0.020 |
Why?
|
| Synaptosomes | 1 | 2008 | 19 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2010 | 905 | 0.020 |
Why?
|
| Self Concept | 1 | 2009 | 156 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2010 | 294 | 0.020 |
Why?
|
| Interneurons | 1 | 2009 | 146 | 0.020 |
Why?
|
| Dendrites | 1 | 2009 | 180 | 0.020 |
Why?
|
| Immunization | 1 | 1989 | 269 | 0.020 |
Why?
|
| Anesthesia | 1 | 2010 | 208 | 0.020 |
Why?
|
| Sleep, REM | 2 | 1991 | 16 | 0.020 |
Why?
|
| Ambulatory Care Facilities | 1 | 2009 | 231 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2009 | 1013 | 0.020 |
Why?
|
| Phenobarbital | 1 | 1986 | 32 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 1986 | 2065 | 0.020 |
Why?
|
| Oxygen | 1 | 2010 | 548 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2010 | 487 | 0.020 |
Why?
|
| Research Design | 1 | 1991 | 716 | 0.020 |
Why?
|
| Spectrum Analysis | 1 | 2006 | 59 | 0.020 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2006 | 7 | 0.020 |
Why?
|
| Mathematical Computing | 1 | 2006 | 9 | 0.020 |
Why?
|
| Syndrome | 1 | 2009 | 1155 | 0.020 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2006 | 25 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2007 | 352 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2009 | 1211 | 0.010 |
Why?
|
| Respiration | 2 | 1984 | 117 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2008 | 825 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2008 | 1105 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2010 | 749 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2006 | 414 | 0.010 |
Why?
|
| Texas | 2 | 2007 | 3686 | 0.010 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2007 | 237 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2008 | 1571 | 0.010 |
Why?
|
| Evoked Potentials, Visual | 1 | 1984 | 29 | 0.010 |
Why?
|
| Evoked Potentials, Auditory | 1 | 1984 | 45 | 0.010 |
Why?
|
| Arousal | 1 | 1984 | 75 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2009 | 2326 | 0.010 |
Why?
|
| Patient Selection | 1 | 2007 | 729 | 0.010 |
Why?
|
| Light | 1 | 1984 | 166 | 0.010 |
Why?
|
| Brain Stem | 1 | 1984 | 108 | 0.010 |
Why?
|
| Double-Blind Method | 2 | 1986 | 1626 | 0.010 |
Why?
|
| Hepatitis C | 1 | 2007 | 381 | 0.010 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2006 | 361 | 0.010 |
Why?
|
| Mass Screening | 1 | 2009 | 822 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 2007 | 496 | 0.010 |
Why?
|
| Mice | 2 | 2009 | 18301 | 0.010 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2007 | 514 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 1984 | 327 | 0.010 |
Why?
|
| Pons | 1 | 1981 | 34 | 0.010 |
Why?
|
| Horseradish Peroxidase | 1 | 2001 | 14 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2009 | 3819 | 0.010 |
Why?
|
| Axonal Transport | 1 | 2001 | 24 | 0.010 |
Why?
|
| Pediatrics | 1 | 2010 | 1252 | 0.010 |
Why?
|
| Cell Count | 1 | 2001 | 212 | 0.010 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2001 | 102 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2006 | 17753 | 0.010 |
Why?
|
| Depression | 1 | 2009 | 1320 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 4738 | 0.010 |
Why?
|
| Adolescent | 5 | 1995 | 20987 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1979 | 101 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 2904 | 0.010 |
Why?
|
| Memory Disorders | 1 | 2001 | 204 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2009 | 4066 | 0.010 |
Why?
|
| Coloring Agents | 1 | 1999 | 71 | 0.010 |
Why?
|
| Prognosis | 2 | 1988 | 4886 | 0.010 |
Why?
|
| Memory | 1 | 2001 | 314 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 2010 | 1889 | 0.010 |
Why?
|
| Cerebral Hemorrhage | 1 | 1979 | 158 | 0.010 |
Why?
|
| Vocational Guidance | 1 | 1977 | 1 | 0.010 |
Why?
|
| Tuberous Sclerosis | 1 | 1979 | 147 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 1591 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1980 | 1618 | 0.010 |
Why?
|
| Universities | 1 | 1977 | 125 | 0.010 |
Why?
|
| Down Syndrome | 1 | 1979 | 233 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 1997 | 274 | 0.010 |
Why?
|
| Task Performance and Analysis | 1 | 1995 | 81 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1995 | 241 | 0.010 |
Why?
|
| United States | 1 | 2010 | 12072 | 0.010 |
Why?
|
| Stereotaxic Techniques | 1 | 1995 | 102 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1999 | 1246 | 0.010 |
Why?
|
| Pregnancy | 1 | 2007 | 7512 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1995 | 808 | 0.010 |
Why?
|
| Anomia | 1 | 1992 | 2 | 0.010 |
Why?
|
| Verbal Behavior | 1 | 1992 | 45 | 0.010 |
Why?
|
| Speech Perception | 1 | 1992 | 53 | 0.010 |
Why?
|
| Temporal Lobe | 1 | 1992 | 110 | 0.010 |
Why?
|
| Microcomputers | 1 | 1991 | 11 | 0.010 |
Why?
|
| Wakefulness | 1 | 1991 | 103 | 0.000 |
Why?
|
| Neuropsychological Tests | 1 | 1992 | 960 | 0.000 |
Why?
|
| Atrophy | 1 | 1986 | 247 | 0.000 |
Why?
|
| Developmental Disabilities | 1 | 1988 | 781 | 0.000 |
Why?
|
| Intellectual Disability | 1 | 1988 | 1089 | 0.000 |
Why?
|
| Electrooculography | 1 | 1978 | 6 | 0.000 |
Why?
|
| Galvanic Skin Response | 1 | 1978 | 10 | 0.000 |
Why?
|
| Electromyography | 1 | 1978 | 134 | 0.000 |
Why?
|
| Electrocardiography | 1 | 1978 | 970 | 0.000 |
Why?
|